This distinguishes these agents from sodium-glucose cotransporter-2 (SGLT2) inhibitors, another diabetes medication class that does carry a well-documented increased risk of genital mycotic infections due to their mechanism of causing glucosuria
GLP-1 receptors are expressed in several tissues in the body, including the gastrointestinal tract, heart, lung, kidney, and brain
Retatrutide Regulatory Status As of June 2026, retatrutide is not approved by the FDA, the EMA, or any other regulatory agency
It works continuously inside cells to help reduce oxidative damage and maintain cellular stability
Splitting daily intake into 5 to 6 smaller portions of 200 to 300 calories each reduces the osmotic load reaching the colon at any one time